Partner with Us
Solving beyond the solution
Helping our pharmaceutical partners simplify, automate, and accelerate the path to market—and a better patient experience.
featured
Partners in Progress
Commercial Partner
A global allergy solutions company, ALK supports a wide range of allergy treatments, services, and products that meet the needs of allergy sufferers around the world.
Investor & Strategic Partner
With over 175 providers in 20 states, Allergy Partners, P.A. is the largest allergy, asthma, and immunology practice in the United States.
Academic Partner
$3.2 Million Grant Sponsored by the National Institutes of Health
Our collaboration received NIH funding to help develop an IM, wet/dry autoinjector that can rescue fire victims and first responders from cyanide exposure due to smoke inhalation.
Investor & Strategic Partner
A Koch Industries subsidiary, Molex is a globally recognized provider of multi-dimensional, cross-industry solutions.
Recent Feasibility Data
99%
Reduction
IN ADMINISTRATION TIME
In one feasibility study, the LVDC device reduced the mixing time from 2 HOURS to a mixed and delivered dose in less than 60 seconds.
This same feasibility study also achieved delivery of a 2mL dose using a 25XTW needle, outperforming the customer’s previous method that required a larger 23XTW needle and a more labor-intensive mixing process.
<8
Seconds
TWO DRUGS CO-ADMINISTERED IN UNDER 8 SECONDS
In another feasibility study, the LVDC device co-administered two sequential doses of two 2mL, 38.25cP doses through a 29-gauge needle in less than 8 seconds.
The study also achieved sequential delivery of two 3mL, 110.5 cP combined therapy through a 27-gauge needle in under 15 seconds.
2
Steps
REDUCING A 16-STEP ADMINISTRATION PROCESS
Current complex drug therapies require upwards of 16 steps to prepare, dose, mix, and inject life-changing medications—and this doesn’t include the time it often takes to bring therapies up to room temperature and administer them within an often time-sensitive window.
Click here to learn how we inject simplicity into complex drug administration.